Otros idiomas ChengDu ShengNuo Biotec Co.,Ltd.

Acciones

688117

CNE1000051M8

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 27/06/2024			Varia. Cinco días.	Varia. 1 de enero.
23,4 ^CNY	-2,01 %		+7,73 %	-17,02 %

22/04	ChengDu ShengNuo Biotec Co.,Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
23/02	ChengDu ShengNuo Biotec Co.,Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection	07/05
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Cheng Du Sheng Nuo Biotec Completes US FDA Filing For Constipation Drug API	15/11
Biocells Biotechnology Co., Ltd. announced that it has received funding from ChengDu ShengNuo Biotec Co.,Ltd., Xiamen Gaoxin Kechuang Angel Venture Capital Co., Ltd., Green Pine Capital Partners Co., Ltd.	31/10/23
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
ChengDu ShengNuo Biotec Co.,Ltd. cancelled the transaction announced on May 16, 2023	20/10/23
Sheng Nuo Biotec's Unit Gets Nod to Amend Usage of Carbetocin Injection	07/09/23
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	16/08/23
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/02/23
Three Cheng Du Sheng Nuo Biotec Execs to Divest Stakes	04/11/22
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
GermanLitho announced that it has received funding from Jingzhou Huaying Capital Venture Capital Management Partnership Enterprise (L.P.), ChengDu ShengNuo Biotec Co.,Ltd.	16/09/22
WNL Biomedtech announced that it has received funding from Huaying Capital, ChengDu ShengNuo Biotec Co.,Ltd.	16/09/22
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22
ChengDu ShengNuo Biotec Co.,Ltd.(SHSE:688117) added to Shanghai Stock Exchange Composite Index	03/06/22
ChengDu ShengNuo Biotec Co.,Ltd.(SHSE:688117) added to Shanghai Stock Exchange A Share Index	03/06/22
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas ChengDu ShengNuo Biotec Co.,Ltd.

Acciones

688117

CNE1000051M8

Otros idiomas

Filtros